Sanara MedTech Inc. (NASDAQ: SMTI) is a Healthcare company (Medical - Instruments & Supplies) with a market capitalization of $301M. The Maz Rating grades it against the other companies in its sector.
Sanara MedTech Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $32.73, Sanara MedTech Inc. trades at 2.7x sales and 37.6x book value, with an EV/EBITDA of 45.3. Over the last twelve months it generated about $112M of revenue and a net loss of $3M. It runs a gross margin of 91.8%, an operating margin of 7.2% and a net margin of -2.7%. It shows return on equity of -42.2%, return on invested capital of 14.3% and a free cash flow yield of 2.4%. On the balance sheet: a debt-to-equity ratio of 6.35 and a current ratio of 2.24. Over the past 52 weeks the share price ranged from $16.05 to $35.52, with a beta of 1.20.
Sanara MedTech Inc. does not currently pay a dividend.
3 Wall Street analyst ratings cover the stock: 2 Buy and 1 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.